Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 2
1995 3
1996 1
1997 1
1999 1
2000 3
2001 1
2002 1
2003 3
2004 2
2006 2
2007 6
2008 4
2009 7
2010 6
2011 9
2012 7
2013 7
2014 6
2015 12
2016 4
2017 10
2018 12
2019 13
2020 21
2021 26
2022 36
2023 30
2024 31
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Superstable lipid vacuoles endow cartilage with its shape and biomechanics.
Ramos R, Pham KT, Prince RC, Leiser-Miller LB, Prasad MS, Wang X, Nordberg RC, Bielajew BJ, Hu JC, Yamaga K, Oh JW, Peng T, Datta R, Astrowskaja A, Almet AA, Burns JT, Liu Y, Guerrero-Juarez CF, Tran BQ, Chu YL, Nguyen AM, Hsi TC, Lim NT, Schoeniger S, Liu R, Pai YL, Vadivel CK, Ingleby S, McKechnie AE, van Breukelen F, Hoehn KL, Rasweiler JJ 4th, Kohara M, Loughry WJ, Weldy SH, Cosper R, Yang CC, Lin SJ, Cooper KL, Santana SE, Bradley JE, Kiebish MA, Digman M, James DE, Merrill AE, Nie Q, Schilling TF, Astrowski AA, Potma EO, García-Castro MI, Athanasiou KA, Behringer RR, Plikus MV. Ramos R, et al. Among authors: nguyen am. Science. 2025 Jan 10;387(6730):eads9960. doi: 10.1126/science.ads9960. Epub 2025 Jan 10. Science. 2025. PMID: 39787221 Free article.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J, Nguyen AM, Li Q, Tzontcheva A, Iskold B, Green SA, Rosa C, Muccino DR, Smith JA; COUGH-1 and COUGH-2 Investigators. McGarvey LP, et al. Among authors: nguyen am. Lancet. 2022 Mar 5;399(10328):909-923. doi: 10.1016/S0140-6736(21)02348-5. Lancet. 2022. PMID: 35248186 Clinical Trial.
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study.
Dent R, Cortés J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Haiderali A, Jia L, Nguyen AM, Pan W, O'Shaughnessy J, Schmid P. Dent R, et al. Among authors: nguyen am. J Natl Cancer Inst. 2024 Oct 1;116(10):1654-1663. doi: 10.1093/jnci/djae129. J Natl Cancer Inst. 2024. PMID: 38913881 Free PMC article. Clinical Trial.
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Schmid P, Lipatov O, Im SA, Goncalves A, Muñoz-Couselo E, Lee KS, Tamura K, Testa L, Witzel I, Ohtani S, Turner N, Zambelli S, Harbeck N, Andre F, Dent R, Mejia JA, Zhou X, Haiderali A, Nguyen AM, Cortes J, Winer EP. Schmid P, et al. Among authors: nguyen am. Eur J Cancer. 2023 Dec;195:113393. doi: 10.1016/j.ejca.2023.113393. Epub 2023 Oct 21. Eur J Cancer. 2023. PMID: 37976633 Clinical Trial.
How to Manage a Patient with Ocular Metastases?
Thariat J, Boudin L, Loria O, Nguyen AM, Kodjikian L, Mathis T. Thariat J, et al. Among authors: nguyen am. Biomedicines. 2022 Nov 25;10(12):3044. doi: 10.3390/biomedicines10123044. Biomedicines. 2022. PMID: 36551800 Free PMC article. Review.
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
Cescon DW, Schmid P, Rugo HS, Im SA, Md Yusof M, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Haiderali A, Zhou X, Guo Z, Nguyen AM, Cortes J. Cescon DW, et al. Among authors: nguyen am. J Natl Cancer Inst. 2024 May 8;116(5):717-727. doi: 10.1093/jnci/djad240. J Natl Cancer Inst. 2024. PMID: 38070159 Clinical Trial.
257 results